Vitrolife
175
SEK
+2.4 %
Less than 1K followers
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+2.4%
-11.84%
-18.6%
-18.22%
-29.38%
-13.11%
-36.91%
+32.38%
+2,751.56%
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Read moreMarket cap
23.7B SEK
Turnover
37.35M SEK
Revenue
3.61B
EBIT %
21.7 %
P/E
46.17
Dividend yield-%
0.63 %
Financial calendar
24.4
2025
Interim report Q1'25
29.4
2025
General meeting '25
30.4
2025
Annual dividend
All
Press releases
3rd party
ShowingAll content types
Vitrolife AB (publ): The Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer
Redeye: Vitrolife Update - Modest stable growth with great margins
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools